SCOT FLYNN

Child, Adolescent & Adult Psychiatry, Psychopharmacology, Psychiatric Research

Scot Flynn, PA-C, is Board-Certified and has been awarded CAQ , Certificate of Advanced Qualifications in Psychiatry with a diverse skill set that encompasses developmental-behavioral pediatrics, psychopharmacology, and addiction medicine.

His clinical tenure includes pivotal roles at eminent institutions such as Yale University's Bridgeport Hospital, Providence Memorial Hospital, Cross Creek Hospital, and Austin Recovery Center where he demonstrated proficiency in both inpatient and outpatient settings.  

Since 2008, Scot has a gained wealth of experience facilitating psychiatric research, and has spearheaded innovative strategies for mental illness treatments, including advances in Ketamine treatments.

His clinical focus extends into addiction psychiatry, providing comprehensive aid for individuals confronting substance use and alcohol use disorders.

In addition, his work has extended to global health initiatives, contributing his medical expertise to underserved communities worldwide . These international endeavors have fundamentally shaped his approach to patient care, underscoring his belief in the vital role of comprehensive mental health treatment in enabling individuals to realize their inherent potential.

• ADHD/ADD

• Bipolar disorder

• Depression

• Schizophrenia

• Autism

• PTSD

• Advanced Psychopharmacology

• Office-Based Ketamine Treatment

• Addiction medicine/Outpatient detox

• Anxiety disorders

• Obsessive Compulsive Disorder (OCD)

​